Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)

NCT00189501 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00189501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00189501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
December 31, 2004
Completion date
Not reported
Enrollment
1,000
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nephrology